Revelation Biosciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics.
Revelation Biosciences stock last closed at $3.05, up 2.76% from the previous day, and has decreased 90.95% in one year. It has underperformed other stocks in the Biotechnology industry by 0.14 percentage points. Revelation Biosciences stock is currently +29.24% from its 52-week low of $2.36, and -94.98% from its 52-week high of $60.80.
As of Apr 30, 2025, there are 905,228 REVB shares outstanding. The market cap of REVB is $2.76M. In the last 24 hours, 39,498 REVB shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy REVB shares.
Based on our experience, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, it's time to fill out some personal information so you are able to buy REVB today.
Now that you have filled out your info on the best stock trading app for beginners, you can securely and quickly fund your account:
Watch the tutorial below if you need help depositing funds into your new investment account.
After you have decided on the best place to buy Revelation Biosciences stock, it's very important to research their stock before you buy, so you actually comprehend the risk as well as the opportunity.
WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on REVB's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge REVB's intrinsic value.
Using relative valuations measures:
You can do additional valuation research on REVB's stock here.
You can dive deeper into what analysts are forecasting on the Revelation Biosciences stock forecast page.
Over the past year, executives and large shareholders at REVB have bought more shares than they have sold.
Jennifer Carver, Director of REVB, was the latest REVB insider to buy. They bought $700.47 worth of REVB stock on Feb 11, 2025.
Dig into more about who owns REVB stock here.
No, Revelation Biosciences doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
You have two main types of orders:
Press the Open button and your broker will execute your order.
If you want additional help with investing in stocks on eToro, click the helpful video below:
Now that you own some REVB shares, you'll want to stay up-to-date on your new stock purchase.
Create a watchlist to see the latest developments about your REVB stock.
To reiterate, here are the 6 steps to buy stock in Revelation Biosciences:
If you require a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Revelation Biosciences, click the button below.